Literature DB >> 1344715

Monoclonal antibody GOM-2 binds to blood group B-Le(y) active glycolipid antigens on human gastric cancer cells, KATO-III.

S Sueyoshi1, H Nagakura, A Kato, S Uetsuki, Y Nakayama, M Adachi.   

Abstract

The antigen structure of a mouse monoclonal antibody, GOM-2, established by immunization with KATO-III human gastric cancer cells, was examined. GOM-2 reactive glycolipids were prepared from KATO-III cells and treated with endoglycoceramidase. Structural studies of ten GOM-2 reactive oligosaccharides by a combination of glycosidase digestions, methylation, and affinity chromatography on an Ulex europeus agglutinin I (UEA-I) column revealed that nine of them had a Y-related B-active difucosylated determinant (B-Le(y)) and one had a B-active determinant. Affinity chromatography of the purified and modified oligosaccharides on an immobilized GOM-2 column demonstrated that GOM-2 has a novel binding specificity: it binds tightly to the biantennary structure carrying the B-Le(y) determinant at the termini or the branched structure carrying the B-Le(y) structure at two nonreducing termini.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1344715     DOI: 10.1007/bf00731706

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  19 in total

1.  Determination of aminosugar linkages in glycolipids by methylation. Aminosugar linkages of ceramide pentasaccharides of rabbit erythrocytes and of Forssman antigen.

Authors:  K Stellner; H Saito; S I Hakomori
Journal:  Arch Biochem Biophys       Date:  1973-04       Impact factor: 4.013

2.  Immunochemical studies on the combining site of the blood group H-specific lectin 1 from Ulex europeus seeds.

Authors:  M E Pereira; E C Kisailus; F Gruezo; E A Kabat
Journal:  Arch Biochem Biophys       Date:  1978-01-15       Impact factor: 4.013

3.  Detection of gangliosides that bind cholera toxin: direct binding of 125I-labeled toxin to thin-layer chromatograms.

Authors:  J L Magnani; D F Smith; V Ginsburg
Journal:  Anal Biochem       Date:  1980-12       Impact factor: 3.365

4.  Novel fucolipids accumulating in human adenocarcinoma. III. A hybridoma antibody (FH6) defining a human cancer-associated difucoganglioside (VI3NeuAcV3III3Fuc2nLc6).

Authors:  Y Fukushi; E Nudelman; S B Levery; S Hakomori; H Rauvala
Journal:  J Biol Chem       Date:  1984-08-25       Impact factor: 5.157

5.  Receptors for peanut agglutinin isolated from cell lines of human Burkitt lymphoma, lung squamous cell carcinoma and gastric signet ring cell carcinoma.

Authors:  T Miyauchi; H Muramatsu; M Ozawa; T Mizuta; T Suzuki; T Muramatsu
Journal:  Gan       Date:  1982-08

6.  Carbohydrate-binding specificities of five lectins that bind to O-Glycosyl-linked carbohydrate chains. Quantitative analysis by frontal-affinity chromatography.

Authors:  S Sueyoshi; T Tsuji; T Osawa
Journal:  Carbohydr Res       Date:  1988-07-15       Impact factor: 2.104

7.  Carbohydrate moieties of peanut agglutinin receptors isolated from human gastric cancer cells.

Authors:  N Shimoda; H Muramatsu; T Osawa; T Yamada; M Adachi; T Muramatsu
Journal:  J Biochem       Date:  1987-09       Impact factor: 3.387

8.  High resolution preparative column chromatographic system for gangliosides using DEAE-Sephadex and a new porus silica, Iatrobeads.

Authors:  T Momoi; S Ando; Y Magai
Journal:  Biochim Biophys Acta       Date:  1976-09-27

9.  Y and blood group B type 2 glycolipid antigens accumulate in a human gastric carcinoma cell line as detected by monoclonal antibody. Isolation and characterization by mass spectrometry and NMR spectroscopy.

Authors:  M Blaszczyk-Thurin; J Thurin; O Hindsgaul; K A Karlsson; Z Steplewski; H Koprowski
Journal:  J Biol Chem       Date:  1987-01-05       Impact factor: 5.157

10.  Novel fucolipids accumulating in human adenocarcinoma. II. Selective isolation of hybridoma antibodies that differentially recognize mono-, di-, and trifucosylated type 2 chain.

Authors:  Y Fukushi; S Hakomori; E Nudelman; N Cochran
Journal:  J Biol Chem       Date:  1984-04-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.